HOT NEWS
Bayer
The Bayer GroupThe Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at www.bayerhealthcare.com.

Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life. Find more information at www.bayerscheringpharma.de.

Bayer RSS Channel

Title Filter     Display # 
# Article Title Hits
1 "Advances in Renal Cancer" Journalists' Award 2011 announced 870
2 Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center 836
3 Bayer Schering Pharma Initiates Phase III Trial of Regorafenib 834
4 Bayer HealthCare Marks 2010 World Hemophilia Day with EUR 250,000 Contribution 800
5 Bayer Successful in a Difficult Environment 1000
6 Visanne® cleared for market launch in Europe as new treatment option for endometriosis 2013
7 Bayer Team wins the "Deutscher Zukunftspreis" awarded by the German President 1074
8 Bayer Schering Pharma to collaborate with Micromet on novel approach to cancer therapy 1338
9 The risk of venous thromboembolism (VTE) associated with oral hormonal contraceptives 1013
10 Bayer Schering Pharma collaborates with AC Immune in the field of Alzheimer's disease 2010
11 Nexavar® Demonstrates 74 Percent Improvement in Progression-Free Survival 1272
12 Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF) 2075
13 New Levitra® formulation submitted for registration in the EU 1017
14 Bayer HealthCare and Genzyme Finalize Strategic Alliance Agreement 820
15 Qlaira® - innovative estradiol-based oral contraceptive available in Europe 1725
16 Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch 785
17 Overall Consensus of the European Nutritionals Press Workshop 1024
18 Bayer Crop Science and the French research organization CNRS intensify collaboration 743
19 Bayer Offers New Betaferon® Titration Pack 1027
20 New image of therapy for erectile difficulties 1554
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share